BioQuiddity is a privately held corporation focused on addressing some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQuiddity's ultimate objective is to provide value to the healthcare community by playing a vital role in containing costs and improving quality via the Company's proprietary unit-dose infusion systems.
Location: United States, California, San Francisco
Total raised: $55M
Investors 2
| Date | Name | Website |
| 06.11.2022 | Hercules C... | htgc.com |
| - | Visionary ... | visionaryp... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.08.2017 | - | $55M | - |
Mentions in press and media 1
| Date | Title | Description |
| 15.08.2017 | BioQ Pharma Secures Financing of up to $55M | BioQ Pharma Incorporated, a San Francisco, CA-based specialty pharmaceutical company, secured new financing of up to $55m. Madryn Asset Management, LP, an alternative asset management firm focused on investments in innovative healthcare com... |